{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:28:48Z","timestamp":1785230928999,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008199","name":"RTI International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.josat.2025.209762","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:45:13Z","timestamp":1753832713000},"page":"209762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Estimates of first-year OTC naloxone sales in four U.S. states with high rates of opioid overdose deaths: KY, MA, NY, OH"],"prefix":"10.1016","volume":"178","author":[{"given":"Doris G.","family":"Gammon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKinley","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Zarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.josat.2025.209762_bb0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jamainternmed.2019.0272","article-title":"Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose","volume":"179","author":"Abouk","year":"2019","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.josat.2025.209762_bb0010","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2025"},{"key":"10.1016\/j.josat.2025.209762_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trsl.2021.03.001","article-title":"Naloxone\u2019s role in the national opioid crisis-past struggles, current efforts, and future opportunities","volume":"234","author":"Bennett","year":"2021","journal-title":"Translational Research: The Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/j.josat.2025.209762_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2022.100126","article-title":"The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses","volume":"6","author":"Bohler","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"2 Pt 1","key":"10.1016\/j.josat.2025.209762_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1475-6773.2012.01449.x","article-title":"Measures of social deprivation that predict health care access and need within a rational area of primary care service delivery","volume":"48","author":"Butler","year":"2013","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2025.209762_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109714","article-title":"County-level predictors of US drug overdose mortality: A systematic review","volume":"242","author":"Cano","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209762_bb0035","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.josat.2025.209762_bb0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/jama.2024.8378","article-title":"Association between cost sharing and naloxone prescription dispensing","volume":"332","author":"Chua","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2025.209762_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.drugalcdep.2018.07.017","article-title":"The changing landscape of naloxone availability in the United States, 2011-2017","volume":"191","author":"Freeman","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209762_bb0050","unstructured":"Gainwell. (n.d.). Preferred drug search. Retrieved 20 Dec, 2024, from https:\/\/spbm.medicaid.ohio.gov\/PreferredDrugSearch\/NDCSearch."},{"key":"10.1016\/j.josat.2025.209762_bb0055","author":"Ghertner"},{"key":"10.1016\/j.josat.2025.209762_bb0060","article-title":"The HEALing (Helping to End Addiction Long-term (SM)) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices","volume":"217","author":"HEALing Communities Study Consortium","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.josat.2025.209762_bb0065","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jama.2023.26969","article-title":"Trends in out-of-pocket costs for and characteristics of pharmacy-dispensed naloxone by payer type","volume":"331","author":"Jiang","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2025.209762_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109505","article-title":"A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder","volume":"237","author":"Jones","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.josat.2025.209762_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.1920","article-title":"Naloxone availability and cost after transition to an over-the-counter product","volume":"5","author":"Marley","year":"2024","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.josat.2025.209762_bb0080","series-title":"MassHealth drug list A - Z","author":"Mass.gov\u00ae","year":"2025"},{"key":"10.1016\/j.josat.2025.209762_bb0085","author":"MedImpact Healthcare Systems"},{"key":"10.1016\/j.josat.2025.209762_bb0090","unstructured":"New York State Medicaid Members. (n.d.). Search for prescription drugs and OTC products: Benefits and information. Retrieved 11 Feb, 2025, from https:\/\/member.emedny.org\/pharmacy\/search-drugs."},{"key":"10.1016\/j.josat.2025.209762_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109668","article-title":"Evaluating equity in community-based naloxone access among racial\/ethnic groups in Massachusetts","volume":"241","author":"Nolen","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2025.209762_bb0100","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/1468-0009.12470","article-title":"Situating the continuum of overdose risk in the social determinants of health: A new conceptual framework","volume":"98","author":"Park","year":"2020","journal-title":"Milbank Quarterly"},{"issue":"8","key":"10.1016\/j.josat.2025.209762_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.2663","article-title":"Trends in out-of-pocket costs for naloxone by drug brand and payer in the US, 2010-2018","volume":"3","author":"Peet","year":"2022","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.josat.2025.209762_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2021.100031","article-title":"Effectiveness of policies for addressing the US opioid epidemic: A model-based analysis from the Stanford-Lancet Commission on the North American Opioid Crisis","volume":"3","author":"Rao","year":"2021","journal-title":"The Lancet Regional Health \u2013 Americas"},{"key":"10.1016\/j.josat.2025.209762_bb0115","unstructured":"Robert Graham Center. (n.d.). Social Deprivation Index (SDI). Retrieved 20 Dec, 2024, from https:\/\/www.graham-center.org\/maps-data-tools\/social-deprivation-index.html."},{"key":"10.1016\/j.josat.2025.209762_bb0120","author":"SAMHSA"},{"issue":"1","key":"10.1016\/j.josat.2025.209762_bb0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/add.15163","article-title":"Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States","volume":"116","author":"Smart","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209762_bb0130","unstructured":"U.S. Census. (n.d.). Relationship files. Retrieved 20 Dec, 2024, from https:\/\/www.census.gov\/geographies\/reference-files\/time-series\/geo\/relationship-files.2020.html#zctacomp."},{"key":"10.1016\/j.josat.2025.209762_bb0135","author":"U.S. Food & Drug Administration"},{"key":"10.1016\/j.josat.2025.209762_bb0140","author":"U.S. Food & Drug Administration"},{"issue":"2","key":"10.1016\/j.josat.2025.209762_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/29767342241289008","article-title":"Naloxone distribution models in the United States: A scoping review","volume":"46","author":"Vadiei","year":"2024","journal-title":"Substance Use & Addiction Journal"},{"key":"10.1016\/j.josat.2025.209762_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108127","article-title":"Socioeconomic marginalization and opioid-related overdose: A systematic review","volume":"214","author":"van Draanen","year":"2020","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:30:54Z","timestamp":1772922654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"alternative-id":["S2949875925001419"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209762","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimates of first-year OTC naloxone sales in four U.S. states with high rates of opioid overdose deaths: KY, MA, NY, OH","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209762"}}